NO20052443D0 - 7-fenylpyrazolpyridinforbindelser - Google Patents
7-fenylpyrazolpyridinforbindelserInfo
- Publication number
- NO20052443D0 NO20052443D0 NO20052443A NO20052443A NO20052443D0 NO 20052443 D0 NO20052443 D0 NO 20052443D0 NO 20052443 A NO20052443 A NO 20052443A NO 20052443 A NO20052443 A NO 20052443A NO 20052443 D0 NO20052443 D0 NO 20052443D0
- Authority
- NO
- Norway
- Prior art keywords
- compound
- fenylpyrazolpyridinforbindelser
- äwherein
- tetrahydropyranyl
- methoxymethyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 methoxy, methylthio, ethyl Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 abstract 1
- 102100038018 Corticotropin-releasing factor receptor 1 Human genes 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002306695 | 2002-10-22 | ||
US42107102P | 2002-10-25 | 2002-10-25 | |
PCT/JP2003/013490 WO2004037822A1 (ja) | 2002-10-22 | 2003-10-22 | 7−フェニルピラゾロピリジン化合物 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20052443D0 true NO20052443D0 (no) | 2005-05-20 |
NO20052443L NO20052443L (no) | 2005-07-22 |
NO331294B1 NO331294B1 (no) | 2011-11-21 |
Family
ID=32179072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052443A NO331294B1 (no) | 2002-10-22 | 2005-05-20 | 7-fenylpyrazolpyridinforbindelser, terapeutisk eller profylaktisk middel omfattende en slik forbindelse, samt anvendelse derav |
Country Status (22)
Country | Link |
---|---|
US (2) | US7323569B2 (no) |
EP (1) | EP1555265B1 (no) |
JP (1) | JP4322211B2 (no) |
KR (1) | KR100984085B1 (no) |
AT (1) | ATE426600T1 (no) |
AU (1) | AU2003275589B2 (no) |
BR (1) | BRPI0313976B8 (no) |
CA (1) | CA2494574C (no) |
CY (1) | CY1110319T1 (no) |
DE (1) | DE60326869D1 (no) |
DK (1) | DK1555265T3 (no) |
ES (1) | ES2322143T3 (no) |
HK (1) | HK1081536A1 (no) |
MX (1) | MXPA05002185A (no) |
NO (1) | NO331294B1 (no) |
NZ (1) | NZ538860A (no) |
PL (1) | PL213633B1 (no) |
PT (1) | PT1555265E (no) |
RU (1) | RU2327699C2 (no) |
SI (1) | SI1555265T1 (no) |
TW (1) | TWI283679B (no) |
WO (1) | WO2004037822A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
ATE426600T1 (de) * | 2002-10-22 | 2009-04-15 | Eisai R&D Man Co Ltd | 7-phenylpyrazolopyridinverbindungen |
WO2005100354A1 (ja) * | 2004-04-12 | 2005-10-27 | Eisai R & D Management Co., Ltd. | ピラゾール縮合環誘導体の製造方法 |
CN102532180B (zh) * | 2005-12-30 | 2016-06-29 | 安纳考尔医药公司 | 含硼的小分子 |
BRPI0817839A2 (pt) | 2007-10-18 | 2015-06-16 | Eisai R&D Man Co Ltd | Método para produzir derivado de anel fundido de pirazol |
KR101601994B1 (ko) * | 2008-04-15 | 2016-03-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 3-페닐피라졸로[5,1-b]티아졸 화합물 |
EP2487177A1 (en) * | 2009-10-08 | 2012-08-15 | Eisai R&D Management Co., Ltd. | Pyrazoloxazole compound |
AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
EP2869822B1 (en) * | 2012-07-09 | 2016-09-14 | Janssen Pharmaceutica, N.V. | Inhibitors of phosphodiesterase 10 enzyme |
EP3321272B1 (en) * | 2015-08-14 | 2019-11-27 | Neuboron Medtech Ltd. | Method for preparing l-bpa |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925849A (en) | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
US5338743A (en) | 1988-06-06 | 1994-08-16 | Fujisawa Pharmaceutical Co., Ltd. | New use of the adenosine antagonist |
JPH085790B2 (ja) | 1988-11-11 | 1996-01-24 | 杏林製薬株式会社 | 記憶障害改善薬 |
DE3942357A1 (de) | 1989-12-21 | 1991-06-27 | Boehringer Mannheim Gmbh | 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel |
DE3942356A1 (de) | 1989-12-21 | 1991-06-27 | Boehringer Mannheim Gmbh | Verwendung von 1-arylsemicarbaziden zur stabilisierung von enzymsubstraten, entsprechende verfahren und diagnostisches mittel enthaltend einen solchen stabilisator |
FR2687675B1 (fr) | 1992-01-31 | 1997-04-18 | Roussel Uclaf | Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. |
AU4293393A (en) | 1992-06-17 | 1994-01-04 | Upjohn Company, The | Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
AU690079B2 (en) | 1992-12-17 | 1998-04-23 | Pfizer Inc. | Substituted pyrazoles as CRF antagonists |
WO1994013676A1 (en) | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrrolopyrimidines as crf antagonists |
TW370529B (en) | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
CZ284157B6 (cs) | 1992-12-17 | 1998-08-12 | Pfizer Inc. | Pyrazolové a pyrazolopyrimidinové sloučeniny jako takové a pro léčbu chorob a farmaceutické prostředky na jejich bázi |
FR2701708B1 (fr) | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
DE4311460A1 (de) | 1993-04-08 | 1994-10-13 | Boehringer Mannheim Gmbh | Verfahren zur kolorimetrischen Bestimmung eines Analyten mittels Benzylalkoholdehydrogenase und einem chromogenen Redoxindikator |
CN1142817A (zh) | 1993-10-12 | 1997-02-12 | 杜邦麦克制药有限公司 | 1n-烷基-n-芳基嘧啶胺及其衍生物 |
FR2714059B1 (fr) | 1993-12-21 | 1996-03-08 | Sanofi Elf | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
ATE182332T1 (de) | 1994-06-16 | 1999-08-15 | Pfizer | Pyrazolo und pyrrolopyridine |
PT882051E (pt) | 1996-02-07 | 2002-04-29 | Janssen Pharmaceutica Nv | Tiofenopirimidinas |
ATE336495T1 (de) | 1996-02-07 | 2006-09-15 | Neurocrine Biosciences Inc | Pyrazolopyrimidine als crf rezeptor-antagonisten |
US6022978A (en) | 1996-06-11 | 2000-02-08 | Pfizer Inc. | Benzimidazole derivatives |
ATE340176T1 (de) | 1996-08-28 | 2006-10-15 | Pfizer | Substituierte 6,5-heterobicyclische-derivate |
WO1998035967A2 (en) * | 1997-02-18 | 1998-08-20 | Neurocrine Biosciences, Inc. | Biazacyclic crf antagonists |
HUP0100179A3 (en) | 1997-07-03 | 2002-12-28 | Bristol Myers Squibb Pharma Co | Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof |
AU9021598A (en) | 1997-08-22 | 1999-03-16 | Du Pont Pharmaceuticals Company | Nitrogen substituted imidazo{4,5-c}pyrazoles as corticotropin relea sing hormone antagonists |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
US6271380B1 (en) | 1998-12-30 | 2001-08-07 | Dupont Pharmaceuticals Company | 1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands |
AU4203500A (en) | 1999-04-06 | 2000-10-23 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
AU4331500A (en) | 1999-04-06 | 2000-10-23 | Du Pont Pharmaceuticals Company | Pyrazolotriazines as crf antagonists |
JP3795305B2 (ja) * | 1999-07-19 | 2006-07-12 | 田辺製薬株式会社 | 医薬組成物 |
FR2801308B1 (fr) | 1999-11-19 | 2003-05-09 | Oreal | COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES |
AU3264201A (en) | 1999-12-17 | 2001-06-25 | Du Pont Pharmaceuticals Company | Imidazopyrimidinyl and imidazopyridinyl derivatives |
WO2002006286A2 (en) | 2000-07-14 | 2002-01-24 | Bristol-Myers Squibb Pharma Company | IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
MXPA03006484A (es) | 2001-01-26 | 2003-09-22 | Bristol Myers Squibb Co | Derivados de imidazolilo como inhibidores del factor de liberacion de corticotropina. |
KR100876622B1 (ko) * | 2001-04-27 | 2008-12-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피라졸로[1,5-a]피리딘 화합물 및 그 의약 |
MY140707A (en) * | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
EP1485384A1 (en) * | 2002-03-13 | 2004-12-15 | Pharmacia & Upjohn Company LLC | Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
ATE426600T1 (de) * | 2002-10-22 | 2009-04-15 | Eisai R&D Man Co Ltd | 7-phenylpyrazolopyridinverbindungen |
US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
-
2003
- 2003-10-22 AT AT03758781T patent/ATE426600T1/de active
- 2003-10-22 TW TW092129327A patent/TWI283679B/zh not_active IP Right Cessation
- 2003-10-22 KR KR1020057006800A patent/KR100984085B1/ko active IP Right Grant
- 2003-10-22 SI SI200331567T patent/SI1555265T1/sl unknown
- 2003-10-22 MX MXPA05002185A patent/MXPA05002185A/es active IP Right Grant
- 2003-10-22 ES ES03758781T patent/ES2322143T3/es not_active Expired - Lifetime
- 2003-10-22 BR BRPI0313976A patent/BRPI0313976B8/pt active IP Right Grant
- 2003-10-22 NZ NZ538860A patent/NZ538860A/en not_active IP Right Cessation
- 2003-10-22 AU AU2003275589A patent/AU2003275589B2/en not_active Expired
- 2003-10-22 RU RU2005115504/04A patent/RU2327699C2/ru active
- 2003-10-22 PT PT03758781T patent/PT1555265E/pt unknown
- 2003-10-22 JP JP2004546447A patent/JP4322211B2/ja not_active Expired - Lifetime
- 2003-10-22 DE DE60326869T patent/DE60326869D1/de not_active Expired - Lifetime
- 2003-10-22 US US10/524,662 patent/US7323569B2/en not_active Expired - Lifetime
- 2003-10-22 CA CA2494574A patent/CA2494574C/en not_active Expired - Lifetime
- 2003-10-22 DK DK03758781T patent/DK1555265T3/da active
- 2003-10-22 WO PCT/JP2003/013490 patent/WO2004037822A1/ja active Application Filing
- 2003-10-22 PL PL376132A patent/PL213633B1/pl unknown
- 2003-10-22 EP EP03758781A patent/EP1555265B1/en not_active Expired - Lifetime
-
2005
- 2005-05-20 NO NO20052443A patent/NO331294B1/no not_active IP Right Cessation
-
2006
- 2006-02-03 HK HK06101472A patent/HK1081536A1/xx not_active IP Right Cessation
-
2007
- 2007-09-20 US US11/858,160 patent/US20080076943A1/en not_active Abandoned
-
2009
- 2009-06-12 CY CY20091100625T patent/CY1110319T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052443D0 (no) | 7-fenylpyrazolpyridinforbindelser | |
DE60230266D1 (de) | Phenylpyridincarbonyl piperazinderivate | |
DK1720881T3 (da) | 11-hydroxy-5h-(2,1-c)(1,4)benzodiazepin-5-on-derivater som nøglemellemprodukter i fremstilling afc2-substituerede pyrrolobenzodiazepiner | |
NO20034595D0 (no) | Kinolin- og kinazolinderivater med azolylgruppe | |
AP1902A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
GB9625045D0 (en) | Parasiticidal compounds | |
WO2004014913A3 (en) | Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors | |
EA200700441A1 (ru) | НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-κB | |
ATE389653T1 (de) | 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen | |
MXPA06000185A (es) | Derivados de quinazolinas 5-sustituidas. | |
DK1364959T3 (da) | Krystallinske former af pyrimidinnukleosidderivater | |
ATE266026T1 (de) | Benzofurancarboxamide und deren therapeutische verwendung | |
EP1533312A4 (en) | HETERO-BICYCLIC COMPOUNDS | |
DE60330038D1 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
DE60211018D1 (de) | Fungizide thiazolderivate | |
DE60322856D1 (no) | ||
HK1074047A1 (en) | Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |